Clinical Trial Update: Lomecel-B Effects on Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Lomecel-B for mild Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lomecel-B (bone marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Longeveron Inc. | Conditions: Mild Alzheimer's Disease | Phase 2 | Status: COMPLETED